John Neoptolemos

1 clinical trials · Sponsor

Record	Firm	Date
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature (NCT05314998)	John Neoptolemos	2025-01-15

Every clearance here is in the API, with alerts when new ones post.